Rosiglitazone Versus a Sulfonylurea On Progression Of Atherosclerosis In Patients With Heart Disease And Type 2 Diabetes
Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the safety and effectiveness of rosiglitazone against a
sulfonylurea in reducing or slowing the development of atherosclerosis in the blood vessels
of the heart.